Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2017; 7(9): 153-159


Systems Biology paves Pathway and Potential Enzymes Predictions towards Anticancer Drug Methyl Jasmonate Biosynthesis

Dipankar Ghosh.




Abstract

Methyl Jasmonate (MJ) is a potential anticancer drug along with other therapeutic importance. MJ generation is predominantly dependent on plant based route which directly or indirectly interferes with ecosystem and environmental concerns. However, existing microbial platforms are not yet reliable enough to fulfil industrial prospects upon MJ large scale production due to lower productivity, titer and molar yield. To this end, the major objective of this study is to identify an efficient putative metabolic pathway and its corresponding enzyme components following in silico systems biology tools. Main aim of this study is to establish a platform or hypothesis following systems biology which has a great potential to design efficient pathway with corresponding enzymes towards improving MJ biosynthesis in near future. This computational approach helps to design two most promising intermediate metabolic routes of stearic acid to oleic acid biocatalytic conversions considering thermodynamic constraint towards MJ biosynthesis. Furthermore, this in silico combinatorial methodology predicts most energetically favorable downstream bioconversion of oleic acid for MJ biosynthetic circuit design along with novel enzymes identifications. Moreover, the future plan will be to functionalize and validate the entire predicted metabolic pathway through in vivo experimentation in suitable chassis microorganisms for ameliorating MJ biosynthesis.

Key words: Pathway Prediction, In silico, Productivity, Systems Biology, Chassis Microorganisms, Methyl Jasmonate.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.